
Patricia L. Morris
Examiner (ID: 11378)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1203, 1201, 1209, 1625 |
| Total Applications | 3798 |
| Issued Applications | 2697 |
| Pending Applications | 142 |
| Abandoned Applications | 965 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6550270
[patent_doc_number] => 20100016605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'Process'
[patent_app_type] => utility
[patent_app_number] => 11/721874
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3337
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20100016605.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721874
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721874 | Process | Dec 14, 2005 | Issued |
Array
(
[id] => 5596865
[patent_doc_number] => 20060160783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Novel omeprazole forms and related methods'
[patent_app_type] => utility
[patent_app_number] => 11/303503
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8777
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160783.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303503
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303503 | Novel omeprazole forms and related methods | Dec 14, 2005 | Abandoned |
Array
(
[id] => 4677193
[patent_doc_number] => 20080214824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Process for the Preparation of N-(4-Piperidinyl)-N-Ethyl-Phenylacetamides from N-Boc-4-Oxopiperidine'
[patent_app_type] => utility
[patent_app_number] => 11/793284
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2164
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214824.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793284
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793284 | Process for the preparation of N-(4-piperidinyl)-N-ethyl-phenylacetamides from N-Boc-4-oxopiperidine | Dec 13, 2005 | Issued |
Array
(
[id] => 5808402
[patent_doc_number] => 20060094757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Substantially pure cilostazol and processes for making same'
[patent_app_type] => utility
[patent_app_number] => 11/300864
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4120
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094757.pdf
[firstpage_image] =>[orig_patent_app_number] => 11300864
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/300864 | Substantially pure cilostazol and processes for making same | Dec 13, 2005 | Issued |
Array
(
[id] => 5808401
[patent_doc_number] => 20060094756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Substantially pure cilostazol and processes for making same'
[patent_app_type] => utility
[patent_app_number] => 11/300862
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4120
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11300862
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/300862 | Substantially pure cilostazol and processes for making same | Dec 13, 2005 | Issued |
Array
(
[id] => 5596945
[patent_doc_number] => 20060160863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Polymorphic and amorphous forms of 2-{3-[(E)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-N-(4-hydroxy-but-2-ynyl)benzamide'
[patent_app_type] => utility
[patent_app_number] => 11/300017
[patent_app_country] => US
[patent_app_date] => 2005-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8128
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160863.pdf
[firstpage_image] =>[orig_patent_app_number] => 11300017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/300017 | Polymorphic and amorphous forms of 2-{3-[(E)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-N-(4-hydroxy-but-2-ynyl)benzamide | Dec 13, 2005 | Abandoned |
Array
(
[id] => 4765694
[patent_doc_number] => 20080176906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Substituted Pyrrole Derivative'
[patent_app_type] => utility
[patent_app_number] => 11/793113
[patent_app_country] => US
[patent_app_date] => 2005-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38271
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176906.pdf
[firstpage_image] =>[orig_patent_app_number] => 11793113
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/793113 | Substituted Pyrrole Derivative | Dec 12, 2005 | Abandoned |
Array
(
[id] => 5149560
[patent_doc_number] => 20070049620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Cyclic tertiary amine compound'
[patent_app_type] => utility
[patent_app_number] => 11/301296
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62311
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11301296
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/301296 | Cyclic tertiary amine compound | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5302791
[patent_doc_number] => 20090297443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-03
[patent_title] => 'Labeled ALPHA4BETA2 Ligands and Methods Therefor'
[patent_app_type] => utility
[patent_app_number] => 11/721145
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13836
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20090297443.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721145
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721145 | Labeled ALPHA4BETA2 ligands and methods therefor | Nov 30, 2005 | Issued |
Array
(
[id] => 5844601
[patent_doc_number] => 20060122236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Substituted biaryl-carboxylate derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/291560
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14906
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122236.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291560
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291560 | Substituted biaryl-carboxylate derivatives | Nov 30, 2005 | Abandoned |
Array
(
[id] => 4677190
[patent_doc_number] => 20080214821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Method of Preparing Clopidogrel and Intermediates Used Therein'
[patent_app_type] => utility
[patent_app_number] => 11/917794
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5191
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214821.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917794
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917794 | Method of preparing clopidogrel and intermediates used therein | Nov 27, 2005 | Issued |
Array
(
[id] => 425290
[patent_doc_number] => 07271273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-18
[patent_title] => 'Method for the preparation of citalopram'
[patent_app_type] => utility
[patent_app_number] => 11/285922
[patent_app_country] => US
[patent_app_date] => 2005-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1941
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/271/07271273.pdf
[firstpage_image] =>[orig_patent_app_number] => 11285922
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/285922 | Method for the preparation of citalopram | Nov 22, 2005 | Issued |
Array
(
[id] => 8629971
[patent_doc_number] => 08362043
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-01-29
[patent_title] => 'Caspase inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/284366
[patent_app_country] => US
[patent_app_date] => 2005-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17499
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11284366
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/284366 | Caspase inhibitors and uses thereof | Nov 20, 2005 | Issued |
Array
(
[id] => 5231389
[patent_doc_number] => 20070293497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-20
[patent_title] => '2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 11/791204
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24005
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20070293497.pdf
[firstpage_image] =>[orig_patent_app_number] => 11791204
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/791204 | 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease | Nov 17, 2005 | Issued |
Array
(
[id] => 5875463
[patent_doc_number] => 20060167056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Polymorphs of {5-[3-(4,6-Difluoro-1H-benzoimidazol-2-yl)-1H-indazol-5-yl)-4-methyl-pyridin-3-ylmethyl}-ethyl-amine'
[patent_app_type] => utility
[patent_app_number] => 11/281295
[patent_app_country] => US
[patent_app_date] => 2005-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13239
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167056.pdf
[firstpage_image] =>[orig_patent_app_number] => 11281295
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/281295 | Polymorphs of {5-[3-(4,6-Difluoro-1H-benzoimidazol-2-yl)-1H-indazol-5-yl)-4-methyl-pyridin-3-ylmethyl}-ethyl-amine | Nov 15, 2005 | Abandoned |
Array
(
[id] => 5509365
[patent_doc_number] => 20090082572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'PROCESS FOR AMORPHOUS ESOMEPRAZOLE'
[patent_app_type] => utility
[patent_app_number] => 11/718273
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 649
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082572.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718273
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718273 | PROCESS FOR AMORPHOUS ESOMEPRAZOLE | Nov 13, 2005 | Abandoned |
Array
(
[id] => 7591128
[patent_doc_number] => 07662968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-16
[patent_title] => 'Process for preparing lansoprazole'
[patent_app_type] => utility
[patent_app_number] => 11/269211
[patent_app_country] => US
[patent_app_date] => 2005-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8901
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/662/07662968.pdf
[firstpage_image] =>[orig_patent_app_number] => 11269211
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/269211 | Process for preparing lansoprazole | Nov 7, 2005 | Issued |
Array
(
[id] => 5727768
[patent_doc_number] => 20060058529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-16
[patent_title] => 'Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt'
[patent_app_type] => utility
[patent_app_number] => 11/265179
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7676
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20060058529.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265179
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265179 | Method for producing 3-substituted 2-chloro-5-fluoro-pyridine or its salt | Nov 2, 2005 | Issued |
Array
(
[id] => 5614452
[patent_doc_number] => 20060116380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-01
[patent_title] => 'Novel anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/265517
[patent_app_country] => US
[patent_app_date] => 2005-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12726
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20060116380.pdf
[firstpage_image] =>[orig_patent_app_number] => 11265517
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/265517 | Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors | Nov 2, 2005 | Issued |
Array
(
[id] => 5596943
[patent_doc_number] => 20060160861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Novel nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/262953
[patent_app_country] => US
[patent_app_date] => 2005-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12050
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160861.pdf
[firstpage_image] =>[orig_patent_app_number] => 11262953
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/262953 | Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors | Oct 31, 2005 | Issued |